共 50 条
- [1] Antipsychotic polypharmacy reduction versus polypharmacy continuation for people with schizophrenia COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2022, (08):
- [3] Antipsychotic polypharmacy and metabolic syndrome in schizophrenia: a review of systematic reviews BMC PSYCHIATRY, 2018, 18
- [7] Using the needs of WHO to prioritise Cochrane reviews: The case of antipsychotic drugs International Journal of Mental Health Systems, 5
- [8] Using the needs of WHO to prioritise Cochrane reviews: The case of antipsychotic drugs INTERNATIONAL JOURNAL OF MENTAL HEALTH SYSTEMS, 2011, 5